 Home > Active Ingredient News > Infection > MCP: The relationship between the risk of thromboembolism in hospitalized and non-hospitalized patients with new coronary pneumonia

MCP: The relationship between the risk of thromboembolism in hospitalized and non-hospitalized patients with new coronary pneumonia

 Last Update: 2021-10-19
 Source: Internet
 Author: User

Tags

dsdna 1 10

chemical analysis

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Background: There is increasing evidence that there is a potential link between new coronary pneumonia infection and thromboembolism .

There is a potential link between new coronary pneumonia infection and thromboembolism Thromboembolism may affect a series of organs, resulting in: myocardial infarction, ischemic stroke, pulmonary embolism, and deep vein thrombosis.

Patients and methods: A self-controlled case series study covering the entire Scottish general population

Results: Across Scotland, 1,449 people tested positive for new coronary pneumonia and experienced thromboembolic events

Table 1 The association between COVID-19 and the results

Table 2 Subgroup analysis of non-fatal events

Figure the correlation between Covid-19 and non-fatal outcomes

Conclusion: The confirmed new coronary pneumonia infection is related to the increased risk of early myocardial infarction and ischemic stroke.

The confirmed new coronary pneumonia infection is associated with an increased risk of early myocardial infarction and ischemic stroke.

Ho FK, Man KKC, Toshner M,et al, Thromboembolic Risk in Hospitalized and Nonhospitalized COVID-19 Patients: A Self-Controlled Case Series Analysis of a Nationwide Cohort.

Thromboembolic Risk in Hospitalized and Nonhospitalized COVID-19 Patients: A Self-Controlled Case Series Analysis of a Nationwide Cohort.

Leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Sodium cloxacillin

CAS No.: 642-78-4

$3/KG EXW

Isoniazid 54-85-3

CAS No.: 54-85-3

Pharmacy Grade

$2-2.5/KG FOB

Andrographolide

CAS No.: 5508-58-7

$1/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.